Drugs News and Research

RSS
Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

Study shows inequalities in addressing post-acute neurological manifestations of COVID-19

Study shows inequalities in addressing post-acute neurological manifestations of COVID-19

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

Macrodomains represent a unique target for pathogens with pandemic potential

Macrodomains represent a unique target for pathogens with pandemic potential

Machine learning model identifies new risk genes for motor neurone disease

Machine learning model identifies new risk genes for motor neurone disease

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

ACP guidelines: Uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics

ACP guidelines: Uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

An alternative mouse model of SARS-CoV-2 infection

An alternative mouse model of SARS-CoV-2 infection

DPP4 protein: The connection between severe COVID-19 and diabetes

DPP4 protein: The connection between severe COVID-19 and diabetes

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Researchers investigate the role of a key component of the circadian clock in heart disease

Researchers investigate the role of a key component of the circadian clock in heart disease